Jazz Pharmaceuticals (JAZZ) free cash flow

Free cash flow · fiscal 2025
$1.15B

Jazz Pharmaceuticals (JAZZ) generated free cash flow of $1.15B in fiscal 2025 (the year ended December 31, 2025). That is 15.0% lower than the $1.35B of fiscal 2024. Figures as of 18 Nov 2026, 12:01 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.15B
Change on fiscal 2024
−15.0%
Growth, 5 years
+5.3% a year
Growth, 10 years
+8.7% a year
Highest on record
$1.35Bfiscal 2024
Lowest on record
-$15.93Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Jazz Pharmaceuticals free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 5.3% a year; over ten years the rate was 8.7% a year. Across the 17 fiscal years on record (2009–2025), the highest was $1.35B in fiscal 2024 and the lowest -$15.93M in fiscal 2009.

History · 17 fiscal years

Free cash flow by fiscal year

Jazz Pharmaceuticals free cash flow, year by year

Jazz Pharmaceuticals (JAZZ) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.15B 15.0% down
2024$1.35B 28.5% up
2023$1.05B 35.6% up
2022$773.78M 3.1% up
2021$750.87M 15.1% down
2020$884.64M 20.2% up
2019$736.27M 5.4% down
2018$778.53M 17.2% up
2017$664.14M 14.0% up
2016$582.70M 17.5% up
2015$495.99M 33.6% up
2014$371.26M 33.3% up
2013$278.46M 14.2% up
2012$243.78M 62.2% up
2011$150.32M 158.6% up
2010$58.14M—
2009-$15.93M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Jazz Pharmaceuticals and comparable companies
CompanyFree cash flowFiscal year
Ascendis Pharma ASND€45.41M2025
ICON ICLR$861.99M2025
Jazz Pharmaceuticals JAZZ$1.15B2025
Solventum SOLV-$10.00M2025
BridgeBio Pharma BBIO-$455.50M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on JAZZ

Jazz Pharmaceuticals, figure by figure

Jazz Pharmaceuticals (JAZZ) overview: price, valuation and scorecardAll health care companies by market value

Jazz Pharmaceuticals free cash flow: questions and answers

What is Jazz Pharmaceuticals's free cash flow?

Jazz Pharmaceuticals (JAZZ) generated free cash flow of $1.15B in fiscal 2025 (the year ended December 31, 2025). That is 15.0% lower than the $1.35B of fiscal 2024.

What is the growth rate of Jazz Pharmaceuticals's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 5.3% a year; over ten years the rate was 8.7% a year.

What are the highest and lowest free cash flow figures on record for Jazz Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was $1.35B in fiscal 2024 and the lowest -$15.93M in fiscal 2009.

How is Jazz Pharmaceuticals's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Jazz Pharmaceuticals it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Jazz Pharmaceuticals (JAZZ) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/JAZZ/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.